Objective: Eudaemonic positive psychological health (PPH), such as purpose in life (PIL), may be maintained more than hedonic PPH, such as quality of life (QOL), for patients with amyotrophic lateral sclerosis (ALS) and their caregivers across the disease course. Furthermore, patients' and caregivers' PPH may impact one another. The present study examined (a) PIL and QOL variance structures; (b) PIL and QOL trajectories from diagnosis, approaching death, with disease severity; and (c) between-dyad and within-dyad relationships for PIL and QOL in patients with ALS and their caregivers. Method: PIL and QOL were assessed in patient-caregiver dyads (N ϭ 110) up to 7 times over 18 months. Results: Multilevel models revealed the proportion of variance attributed to stable between-person differences was higher for PIL (patients ϭ 74%; caregivers ϭ 76%) than QOL (patients ϭ 60%; caregivers ϭ 55%). PIL and QOL declined in relation to disease severity and time. For PIL, proximity to diagnosis and death moderated within-person change; decline was generally faster following diagnosis and approaching death. Longitudinal within-dyad relationships revealed that patients' fluctuations in PIL were mirrored in their caregiver and vice versa. Conclusions: PIL was more stable than QOL and was therefore a potential psychological resource for patients and caregivers. Critical periods-after diagnosis and approaching death-accompanied more rapid PIL decline. QOL was also impacted by proximity to critical periods. PIL within-dyad relationships may reflect a shared disease experience. Psychological intervention focused on enhancing purpose, particularly during critical periods, is a promising direction for future study.
described above (general QOL), assessments specific to health and physical functioning domains (health-related QOL), and assessments in which domains are undefined, allowing people to rate their QOL based on their own personal definition of the construct (self-assessed QOL; Hardiman, Hickey, & O'Donerty, 2004) . Notably, people may weigh the importance of QOL domains differently (e.g., one person highly valuing emotional well-being, and another highly valuing physical well-being). The current study evaluates self-assessed QOL in particular, though all three QOL types will be discussed in regard to the previous literature.
PIL is a narrower construct, which offers an assessment of eudaemonic PPH that may be independent from life conditions such as physical disability and disease. PIL reflects people's view of their life's significance, meaning, and fulfillment (Crumbaugh & Maholick, 1964; Reker & Wong, 1988) . In addition to potential independence from decline in physical condition, PIL has also been prospectively associated with better psychological and physical health, including biomarkers (e.g., cardiovascular and immune), decreased disease burden, and lower premature mortality risk (Boyle et al., 2012; R. Cohen, Bavishi, & Rozanski, 2016 ; for reviews, see Boehm & Kubzansky, 2012; Ryff, Singer, & Dienberg Love, 2004; Zika & Chamberlain, 1992) . PIL may be especially important in terminal illness because it could be robust to objectively negative changes in life conditions.
Positive Psychological Health in Patients With ALS and Caregivers
Most research on PPH in patients with ALS has focused on hedonic PPH, namely, QOL. For patients with ALS, several authors have concluded that general and self-assessed QOL remains preserved over the disease course despite physical decline (Neudert et al., 2004; Robbins et al., 2001; Simmons et al., 2000) , though not all research supports this conclusion (Rabkin, Wagner, & Del Bene, 2000; Roach, Averill, Segerstrom, & Kasarskis, 2009 ). Specifically, general QOL did not significantly decreased over periods of 5 months (Rabkin et al., 2000) , 6 months (Robbins et al., 2001) , or up to 5 years (Roach et al., 2009 ). In one sample, patients' general QOL exhibited a slight but nonsignificant increase over 9 months (Gauthier et al., 2007) . Regarding disease severity, no relationship was found with patients' general QOL and disease severity in one sample (Robbins et al., 2001) , whereas general QOL was significantly correlated with disease severity in another sample (Rabkin et al., 2000) . Another study found a significant correlation between patients' general QOL and disease severity at study entry but not study exit (Gauthier et al., 2007) . Similarly, self-assessed QOL did not significantly decreased over 4 months (Neudert et al., 2004) , though self-assessed QOL significantly decreased as patients approached death (Roach et al., 2009 ). This suggests that centering time at important disease time points (e.g., death) may be important for understanding the relationship between time and QOL in patients with ALS. Patients' self-assessed QOL was not significantly related to disease severity or duration (Neudert et al., 2004; Simmons et al., 2000) . In contrast, heath-related QOL significantly decreased over 4 months (Neudert et al., 2004) and 6 months (Robbins et al., 2001 ). Healthrelated QOL was also significantly correlated with disease severity (Neudert et al., 2004; Robbins et al., 2001; Simmons et al., 2000) . Additionally, caregivers' general QOL significantly decreased with the passage of time since patient diagnosis (Roach et al., 2009 ). In another sample, caregivers' general QOL decreased over 9 months, though not significantly (Gauthier et al., 2007) .
Less is known about eudaemonic PPH in patients with ALS and their caregivers, although existing research suggests that eudaemonic PPH aspects may change independently from hedonic aspects. For example, one study compared general QOL, weighted more heavily by hedonic aspects, with an existential QOL subscale, weighted more heavily by eudaemonic aspects. This study utilized the McGill Quality of Life Questionnaire (S. R. Cohen, Mount, Strobel, & Bui, 1995) , which provides a measure of general QOL consisting of existential QOL, physical QOL, physical symptoms, psychological QOL, and social support. Existential QOL exhibited stability that general QOL did not. The existential QOL subscale was stable among both patients and caregivers over a period up to 5 years, whereas total QOL declined among caregivers (Roach et al., 2009 ). Likewise, a eudaemonic PPH measure characterized as "existential well-being" was uncorrelated with perceived health status and did not significantly differ among disease stage in ALS, suggesting eudaemonic PPH is independent from physical disability (Dal Bello-Haas et al., 2000) . People with ALS who were identified as exceptionally adapted to the disease "developed an enhanced philosophical perspective on life as a result of living with ALS" (Young & McNicoll, 1998, p. 39) , suggesting that resiliency among patients with ALS may be attributed to eudaemonic PPH. In sum, eudaemonia, such as PIL, may be a stable form of PPH despite losses in hedonic PPH aspects, such as QOL.
In ALS, eudaemonia research has been limited to primarily qualitative or cross-sectional research. Moreover, information about longitudinal changes in PPH in relation to disease events is scarce. Diagnosis and death are two critical disease events in the lives of both patients and caregivers. Receiving a fatal diagnosis or having a close other receive such a diagnosis may provoke people to reframe their life, its quality, and their sources of purpose. Existential distress or acceptance as the patient approaches death may also influence purpose in and quality of life. Previous research has also typically treated change in PPH over time the same for all patients. However, heterogeneity among how long patients have been living with their disease and proximity to disease events may obscure PPH patterns of change over time. Therefore, further examination is needed to understand both eudaemonic and hedonic PPH in patients with ALS and their caregivers in relation to disease events (i.e., diagnosis and death).
Dyadic Relationships
ALS has been conceptualized as a family disease (Gauthier et al., 2007) , suggesting that patients and their family may impact one another across the disease experience. Previous cross-sectional research found significant correlations between patient and caregiver PPH and distress (Pagnini et al., 2011; Rabkin et al., 2000) . Although cross-sectional research can examine between-dyad differences at a single point in time, this method does not provide information regarding whether dyads tended to fluctuate together in their PPH. Longitudinal dyadic relationships, on the other hand, allow assessment of the relationship between two people on PPH over time. If longitudinal within-dyad relationships indicate that dyads change together over time, this might suggest that disease This document is copyrighted by the American Psychological Association or one of its allied publishers.
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events affect patients and their caregivers similarly and that they have a shared disease experience. A patient and their caregiver undergo experiences through the patient's disease course that are specific to that pair (e.g., the point at which the patient becomes wheelchair bound, need for supportive interventions). It is also plausible that the PPH of a caregiver may be influenced by the patient's PPH, or vice versa, over the disease course. For example, a patient who maintains high PIL may positively influence their caregiver, buffering negative experiences that occur over the disease course. Moreover, because we are interested in the potential impact a patient has on their caregiver, and vice versa, longitudinal within-dyad analyses are necessary to capture reciprocal relationships between these partners over the disease course. Two types of dyadic relationships are of interest: first, between-dyad covariances, or mean dyad similarity; and second, within-dyad covariance patterns, or longitudinal slopes. In sum, dyadic relationships may reflect similarity in PPH in one dyad compared with other dyads and/or a particular dyad experiencing parallel within-dyad fluctuations in PPH over time. To our knowledge, the within-dyad relationship of PPH in patients with ALS and their caregivers, which assesses mirrored fluctuations over time, has not been examined.
The Current Study
The goal of the present study was to examine the variance and covariance structures, trajectories, and dyadic relationships of PIL and QOL in patients with ALS and their caregivers over the disease course and by doing so, to provide insight to both stability and variability in PPH in the context of ALS, a progressive disease. First, the variance structures (i.e., intraclass correlations) of QOL and PIL provided information about the overall amount of stability and fluctuation in each construct. Given that existential QOL, reflecting eudaemonic PPH, was stable among both patients and caregivers in previous research (Roach et al., 2009) , it was hypothesized that a greater portion of variability in PIL would be attributable to stable between-person differences than to changes within people. Second, this study also provided insight to changes to PPH in relation to critical disease events: diagnosis and death. Patients and their caregivers were assessed in their homes, allowing people with advanced illness to participate. It was hypothesized that for patients, PIL and QOL would not be significantly systematically related to time since diagnosis. For caregivers, it was expected that QOL would systematically decrease over time since patient diagnosis, replicating previous research (Roach et al., 2009) , though PIL would not systematically decrease over the study period. Third, between-and within-dyad PPH relationships for patients and their respective caregivers were evaluated. This goal addressed whether PPH in patients with ALS impacts their caregivers and vice versa. It was hypothesized that patient and caregiver PPH, including both PIL and QOL, would fluctuate together over time.
Method
The Seattle ALS Patient Profile Project began in 1986, and the last study visit occurred in 1989 (McDonald, Wiedenfeld, Hillel, Carpenter, & Walter, 1994 
Participants
The Seattle ALS Patient Profile Project consisted of 143 patients with ALS and 123 caregivers (McDonald et al., 1994) . Inclusion criteria for patients were aged 18 years or older, a confirmed ALS diagnosis by a neurologist, and absence of dementia or alcoholism. The present analysis examines PPH in relation to patients' date of diagnosis and death; nine dyads were excluded because date of diagnosis or death was unknown. Furthermore, we chose to focus on family caregivers; therefore, one dyad was excluded in which the caregiver was paid and unrelated to the patient. Three dyads were excluded because the patient's survival after diagnosis was atypical for ALS (Ͼ20 years). The resulting final sample included in the current study consisted of 130 patients with ALS (86 men, 44 women) and 110 caregivers (31 men, 79 women; 110 dyads). The average patient age at study entry was 61 years (SD ϭ 11) and average caregiver age was 57 years (SD ϭ 14). Disease onset was primarily within the limbs (82.3%). A wide range of patient physical function was included: 16 subjects (12.3%) were on a respirator, and 13 patients (10%) had a feeding tube. The average Amyotrophic Lateral Sclerosis Severity Scale (ALSS; Hillel et al., 1989) score was 24.32 (SD ϭ 8.55) at study entry, reflecting moderate disease severity (see Table 1 for demographics and disease characteristics). Patients completed an average of 4.6 visits (SD ϭ 2.4). Caregivers completed an average of 4.3 visits (SD ϭ 2.5). A total of 1,074 person-visits were available for analysis (patients, n ϭ 603; caregivers, n ϭ 471), corresponding to 64% of all person-visits possible (patients 66%; caregivers 61%; see Table  1 for data contribution). Before completing the study, 43.8% of patients (n ϭ 57) and their caregivers discontinued because the patient died. An additional 10.8% of patients (n ϭ 14) and their caregivers withdrew from the study. All available data was used in the analyses, including dyads that discontinued the study.
Measures
Purpose in life. The Purpose in Life Test is a 20-item scale that assesses the degree to which a person has found meaning and purpose in his or her life (e.g., "My personal existence is very purposeful and meaningful," "If I should die today, I would feel that my life has been worthwhile"; Crumbaugh & Maholick, 1969) . Items are rated on a 7-point scale. The measure provides a single score ranging from 20 to 140, in which scores greater than This document is copyrighted by the American Psychological Association or one of its allied publishers.
112 reflect definite purpose, scores of 92 to 112 reflect an indecisive level, and scores below 92 reflect a lack of clear meaning and purpose (Crumbaugh & Henrion, 1988) . The Purpose in Life Test (Crumbaugh & Maholick, 1969) has demonstrated strong concurrent validity with related measures including the Frankl Questionnaire, the Life Regard Index, the Sense of Coherence Scale, the Meaningful Life Measure, the Meaning in Life Questionnaire, and the Scales of Psychological Well-Being Purpose in Life subscale (Crumbaugh & Maholick, 1964; Debats, 1990; Morgan & Farsides, 2009; Ryff, 1989; Steger, Frazier, Oishi, & Kaler, 2006; Zika & Chamberlain, 1992) . Quality of life. The Life Rating Scale is a single-item selfassessed QOL measure. This item asked individuals to rate his or her QOL on a 5-point scale. A rating of 1 is "uncomfortable" and reflects the lowest QOL, a rating of 2 is "dissatisfied," a rating of 3 is "content," a rating of 4 is "happy," and a rating of 5 is "joyous" and reflects the highest QOL (unpublished scale, ALS Patient Profile Project).
Amyotrophic Lateral Sclerosis Severity Scale. The ALSS measures functional impairment in patients with ALS (Hillel et al., 1989) . Patient functionality or disease severity is rated on four domains: ability to speak, ability to swallow, movement of upper extremities, and movement of lower extremities. A total score is calculated by adding the four domain scores. Domain severity scores ranges from 1 (complete loss of function) to 10 (completely intact function). Total severity scores of 2 to 16 reflect severe disease, scores of 17 to 28 reflect moderate disease, and scores of 29 to 39 reflect mild disease. ALSS scores were reversed for analysis, so higher scores reflect worse disease severity.
Data Analysis
Multilevel modeling (MLM) was utilized to evaluate individual and joint variance and covariance structures and trajectories of PIL and QOL. MLM can accommodate repeated measures and nested data, including dyadic relationships, and allows for the use of all available data without listwise deletion (Singer & Willett, 2003) . Separate analyses were run for patients and caregivers, except for dyadic analyses. Models were implemented using PROC MIXED method in SAS (Version 9.4). Fixed effects and fit statistics were calculated and reported with full maximum likelihood estimation. Random effects were calculated and reported with restricted maximum likelihood estimation likelihood ratio tests using mixture (1/2) degrees of freedom. Note that the estimates and statistical significance for random effects correspond to the overall variance of the random effect, not the estimates of individual random effects.
Unconditional Means Models
The research questions were addressed using increasingly complex models (Singer & Willett, 2003) . First, unconditional means models were applied, which do not include time predictors. These models (i.e., Model 1) yield information about variation in peoples' responses on a single variable. Unconditional means models partition the amount of variability attributable to (a) stable differences between people (i.e., variability that is attributable to differences in person-level means), and (b) fluctuations within people (i.e., within-person fluctuations around their person-level mean). This model can be used to compute the intraclass correlation coefficient (ICC), which is a ratio of the between-person variance to the total variance. The following equation represents an unconditional means model. PIL ij corresponds to PIL at visit i for person j. A person's average PIL score corresponds to ␤ 0j , and e ij is the residual associated with visit i. The person's average score, ␤ 0j , can be expressed in terms of the prototypic intercept or grand mean model parameter, ␥ 00 , and the person's ␤ 0j residual or deviation from the grand mean, 0j . The random term, 0 j, in Level 2 of this model allowed peoples' average PIL to differ from the grand mean model parameter. Gammas (␥) in MLM are comparable to unstandardized beta weights in regression. Unconditional means model (described above): Note. Standard deviations are given in parentheses. PIL ϭ purpose in life; QOL ϭ quality of life; ALSS ϭ amyotrophic lateral sclerosis Severity Scale.
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Growth Models
Unconditional means models established that a significant amount of within-person change existed for PIL and QOL. Therefore, growth models were employed, which added predictors of change in PIL and QOL. To better understand PPH change in regard to time and disease severity, intraindividual variability was examined, which refers to dynamic within-person fluctuations (Ram & Gerstorf, 2009) . In order to examine these within-person fluctuations in the context of the ALS disease course, three systematic ways of modeling the change in PPH were explored. The first two model types aimed to uncover the best functional form of time for PPH, and the third model type aimed to examine the effect of disease severity, as measured by the ALSS. Quadratic and random effects were tested for all models. All models were evaluated for model fit using both fit statistics and explained variance. Model fit was compared using deviance-based hypothesis testing, that is, the change in the Ϫ2 log-likelihood (Ϫ2LL; Singer & Willett, 2003 ) and Akaike's information criterion (AIC); lower numbers indicate better model fit. Incremental within-person variance explained, Level 1 pseudo R 2 , was also used as a model comparison parameter. For time models, the model type that best met these criteria for patients and caregivers was selected.
The first model type applied included a single time predictor centered at patient diagnosis or patient death (i.e., each visit datediagnosis date or date of death). First, our hypothesized model in which PPH was predicted by the passage of time since patient diagnosis was tested. These models resulted in poor fit; these predictors did not result in significant reductions in Ϫ2LL from the unconditional means models for patients' PIL, caregivers' PIL, or patients' QOL. For PIL, within-person residual variance increased rather than decreased for caregivers, and AIC also increased for patients and caregivers. For QOL, within-person residual variance increased rather than decreased for both patients and caregivers. This suggests that these models poorly captured within-person change. Second, a model in which PPH was predicted by the passage of time approaching patient death was tested. These models produced adequate fit for characterizing within-person change in PPH. A quadratic term was tested for both time since diagnosis and time approaching death; these models produced adequate fit to the data.
The second model type applied aimed to better interpret how PPH changes around critical points of the disease (e.g., time since diagnosis at study entry and time to death at study entry; influenced by Gerstorf et al., 2008) . These models included an interaction term accounting for individual differences in proximity to diagnosis and death at study enrollment and the passage of time in the study. Dyads varied in the length of time since patients had been diagnosed with the disease, survival time, and disease severity. Therefore, change in PPH over the course of the study may vary as a function of how far dyads were from critical disease points (i.e., change over time might differ for a patient newly diagnosed and a patient living with ALS for years). These models produced significantly better fit for characterizing within-person change in PPH, above and beyond all of the previously described time models. Therefore, this second model type, the interaction model, was selected as the best functional form for time and is presented in depth below. Because of poorer model fit and in the interest of parsimony, only the final time models selected are presented in the main text. The models corresponding to the original but ultimately unsatisfactory analysis plan can be found in the online supplemental materials (Supplementary Tables 2 to 5 ).
The best-fitting models (i.e., interaction models) separated between-person differences, for example, time since diagnosis at study entry, from within-person changes, for example, passage of time within the study. These models (i.e., Model 2a & 2b) employed three predictors: (a) a main effect between-person predictor consisting of interval from study entry to patient diagnosis or death (i.e., Visit 1 date -diagnosis date or date of death); (b) a main effect within-person predictor consisting of change over time in the study (i.e., each visit date -Visit 1 date); and (c) an interaction term allowing individual trajectories (i.e., effects of the withinperson time in the study predictor) to differ based on the betweenperson differences in proximity to patient diagnosis or death. These analyses described change for PIL and QOL in relation to patient diagnosis or death. Predictor 1 was centered at the sample mean time since diagnosis (patient mean ϭ 18.24 year quarters; caregiver mean ϭ 17.73 year quarters) and time to patient death (patient mean ϭ Ϫ20.97 year quarters; caregiver mean ϭ Ϫ21.36 year quarters) at study entry, so that the intercepts would represent the main effect at the sample mean. Predictor 2 was centered at study entry so that the intercepts would represent the estimate at the first study visit. Time was coded as year quarters (i.e., 3-month increments) in these growth models.
For example, intercepts represent PIL or QOL at the sample mean time since diagnosis at Visit 1. The first coefficient represents the PIL or QOL score change in 3-month increments (year quarters) for between-person differences in time since diagnosis at study enrollment. The second coefficient represents longitudinal PIL or QOL score changes in 3-month increments from Visit 1. The third coefficient represents moderation of the PIL or QOL score at a study visit, adjusted based on time since the patient's diagnosis date at study enrollment.
The following equations represent this between-within interaction model predicting PIL change over time within the study based on between-person differences in time since diagnosis at study entry (i.e., rate of change estimations over the study period were allowed to vary based on the amount of time between when patients received their diagnosis and when they enrolled in the study; Model 2a). The first between-within equation represents the model in terms of MLM Level 1 and Level 2 models, reflecting within-person and between-person variance, respectively. The second, marginal equation represents the same model simplified by substitution. The passage of time in the study within people (T W ) was at Level 1, and time since patient diagnosis at study entry between people (T Bdiagnosis ) was at Level 2. At Level 1, ␤ 0j represents the intercept, centered at study entry, for person j, and ␤ 1j was person j's slope for time in the study, that is, the passage of time during study participation. The term e ij represents person j's residual associated with visit i. At Level 2, ␥ 00 represents the model parameter for the intercept, ␥ 01 represents the model parameter of time since diagnosis at study entry for PIL at study entry, and 0j represents individual differences in the intercept and slope after accounting for time since diagnosis at study entry. ␥ 10 represents the model parameter slope for time in the study at the average time since diagnosis, and ␥ 11 represents the effect of time since diagnosis on the slope for time in the study, that is, passage of time in the study moderated by time since diagnosis at study This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Between-within model (described above):
Level 1
Level 2
Marginal model:
Parallel models were run predicting PIL change over time within the study based on time to patient death at study entry (i.e., rate of change estimations over the study period varied based on the amount of time between when patients enrolled in the study and when they died; Model 2b).
The third model type applied focused on disease severity as a predictor of within-person change. ALS is a progressive disease; therefore, it is possible that time acts as a proxy for disease progression. On the other hand, it is also possible that the pattern of variability in disease severity may capture change that is not adequately captured by linear time. These models (i.e., Model 3) included a single disease severity predictor; ALSS was linearly transformed (40 -score) so higher scores reflect greater disease severity. Disease severity was centered at 1-point of functional impairment (i.e., ALSS ϭ 39), the minimum functional impairment observed in the sample, to represent changes from disease start. These models produced good fit to the data. An exploratory analysis added disease severity to the interaction time growth models to examine whether disease severity explained variance in PPH above and beyond change with time. Disease severity accounted for a negligible amount of additional within-person variance (see Supplementary Table 6 of the online supplemental materials). Another exploratory analysis predicted ALSS scores from the interaction time growth models to determine whether disease progression was largely accounted for by time. Interaction time models accounted for 86% of disease severity variance (see Supplementary Table 7) . Additionally, an exploratory analysis decomposed the effects of disease severity between-person and within-person relationships in regard to PPH. Disease severity within-person deviations from person-level means significantly predicted decreases in PIL and QOL for both patients and caregivers; disease severity between-person mean-level differences only significantly predicted decreases in caregiver QOL (see Supplementary Table 8 ).
Dyadic Models
Finally, dyadic unconditional means models and linear growth models were constructed. Unconditional means models yielded covariance and correlation matrices for between-dyad and withindyad relationships. Linear growth models yielded information about covariance explained by disease severity. Each patient's data was linked to their respective caregiver through dummycoding, which allows for assessment of covariance between two people. Pairing of these two people, a patient and their respective caregiver, is important because these two people's scores are interdependent and hold a relationship that is specific to the pair and is not observed between two random scores within the sample (Kenny, Kashy, & Cook, 2006) . Kenny and colleagues (2006) provide a detailed description of how dyadic models were implemented.
Results

Unconditional Means Models: Variance and Covariance Structures of PIL and QOL
Unconditional means models with no predictors were fit separately for patients and caregivers (Model 1; Table 2 and Table 3 Therefore, approximately three quarters of the variance in PIL was attributable to stable between-person differences (i.e., variance from differences between person-level means and the grand mean), and one quarter of the variance was attributable to within-person fluctuations (i.e., variance from within-person deviations from their person-level mean).
For QOL, intercepts fell between "content" and "dissatisfied" (2.62 for patients, 2.65 for caregivers). ICCs for QOL were .60 for patients and .55 for caregivers (patient iSDs: M ϭ 0.48, range ϭ 0 -2.82; caregiver iSDs: M ϭ 0.55, range ϭ 0 -2.0). Therefore, approximately one half of the variance in QOL was attributable to stable between-person differences, and approximately one half was attributable to within-person fluctuations, consistent with our hypothesis and previous research (Roach et al., 2009) .
A strong correlation was observed for average PIL and QOL collapsed across all subjects and time points (r ϭ .60, p Ͻ .01). However, within-person correlations revealed weaker relationships between PIL and QOL for patients (r ϭ .20, p Ͻ .01) and caregivers (r ϭ .35, p Ͻ .01), suggestive of discriminant validity for PIL and QOL despite some overlap between these variables (see Supplementary Table 1 of the online supplemental materials for all correlations between PIL and QOL).
Growth Models: Diagnosis Date
Growth models examined the effect of time within the study relative to patients' proximity to their diagnosis date at study entry (i.e., setting the intercept at the sample mean for time between diagnosis date and study enrollment) for both patients and caregivers (Model 2a, Tables 2 and 3 ). Three terms are relevant: the effect of time since patient diagnosis at study entry centered at the sample mean (between-person effect; T Bdiagnosis ), the effect of This document is copyrighted by the American Psychological Association or one of its allied publishers.
passage of time within the study centered at the first study visit (within-person effect; T W ), and the moderation of the effect of passage of time within the study by time since patient diagnosis at study entry (interaction effect; T W ϫ T Bdiagnosis ). For PIL, the intercepts in these models represent average PIL at Visit 1 for patients at 18.24 quarter years since their diagnosis (sample mean ϭ 17.73 for caregivers). Intercepts fell in the "indecisive" level of PIL (105.82 for patients, 111.32 for caregivers). Coefficients represent change in 3-month increments from the intercept. There was no statistically significant effect of time since diagnosis at study entry on PIL for either patients or caregivers. A statistically significant decline over time within the study for PIL (patients, ␥ ϭ Ϫ1. Figure 1 illustrates the interaction for patients (effects on caregivers were similar). PIL declined across the course of the study more precipitously for patients and caregivers who enrolled closer to the patient's diagnosis. There were also significant individual differences in the effect of time within the study on PIL (i.e., a random effect) among patients (time within study 1j ϭ 3.56, SE ϭ 1.23, 2 [mixed 1/2, n ϭ 110] ϭ 24.2, p Ͻ .001) and caregivers (time within study 1j ϭ 1.87, SE ϭ .92, 2 [mixed 1/2, n ϭ 110] ϭ 7.8, p ϭ .01). In other words, the effect of time within the study on PIL differed based on the amount of time between when patients were diagnosed and when they enrolled in the study and varied among participants.
For QOL, the intercepts in these models represent average QOL at Visit 1 for patients at 18.24 quarter years since their diagnosis (sample mean ϭ 17.73 for caregivers). Intercepts fell between "dissatisfied" and "content" (2.69 for patients, 2.70 for caregivers). There was no statistically significant effect of time since diagnosis at study entry on QOL for patients. However, caregivers who enrolled in the study closer to the patient diagnosis date had significantly lower QOL (caregivers, ␥ ϭ 0.01, t[106] ϭ 2.01, p ϭ .04). For patients, time to patient death at study entry moderated the effect of time within the study (patients, ␥ ϭ 0.002, t[466] ϭ 2.66, p ϭ .008). QOL declined across the course of the study more precipitously for patients who enrolled closer to their diagnosis. Caregivers did not experience statistically significant decline over time within the study for QOL. However, there were significant individual differences in the effect of time within the study on QOL for caregivers ( 1j ϭ .01, SE ϭ .006, 2 [mixed 1/2, n ϭ 110] ϭ 6.1, p ϭ .03) but not patients.
Growth Models: Date of Death
Growth models examined the effect of time within the study relative to patients' proximity to their date of death at study entry (i.e., setting the intercept at the sample mean for time between study enrollment and date of death) for both patients and caregivers (Model 2b, Tables 2 and 3). As for the previous models, the three relevant terms represent effects of time to patient death at study entry centered at the sample mean (between-person effect; T Bdeath ), the effect of passage of time within the study (within- This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
person effect; T W ), and the moderation of the effect of passage of time within the study by time to patient death at study entry (interaction effect; T W ϫ Bdeath ). For PIL, the intercepts in these models represent average PIL at Visit 1 for patients 20.97 quarter years from their date of death (sample mean ϭ 21.36 for caregivers). Intercepts fell in the "indecisive" level of PIL (106.47 for patients, 111.77 for caregivers). Coefficients represent change in 3-month increments from these intercepts. There was no statistically significant effect of time to patient death at study entry on PIL for patients or caregivers. A statistically significant decline over time within the study for PIL (patients, ␥ ϭ Ϫ1.28, t[462] Figure 2 illustrates the interaction for patients (effects for caregivers were similar). There were also significant individual differences in the effect of time within the study on PIL (i.e., a random effect) among patients (time within study 1j ϭ 3.92, SE ϭ 1.27, 2 [mixed 1/2, n ϭ 110] ϭ 27.6, p Ͻ .001) and caregivers (time within study 1j ϭ 1.71, SE ϭ .90, 2 [mixed 1/2, n ϭ 110] ϭ 6.5, p ϭ .02). In other words, the effect of time within the study on PIL differed based on the amount of time between when patients enrolled in the study and when they died and varied among participants.
For QOL, the intercepts in these models represent average QOL at Visit 1 for patients 20.97 quarter years from their date of death (sample mean ϭ 21.36 for caregivers). Intercepts fell between "dissatisfied" and "content" (2.71 for patients, 2.72 for caregivers). Patients who enrolled in the study closer to their date of death had significantly lower QOL (patients, ␥ ϭ Ϫ0.008, t[128] ϭ Ϫ2.02, p ϭ .04). There was no statistically significant effect of time to patient death at study entry for caregivers. For patients, there was a statistically significant decline over time within the study for QOL (patients, ␥ ϭ Ϫ0.03, t[466] ϭ Ϫ2.19, p ϭ .03). For caregivers, time to patient death at study entry moderated the effect of time within the study (caregivers, ␥ ϭ Ϫ0.002, t[352] ϭ Ϫ2.01, p ϭ .04). QOL declined across the course of the study more precipitously for caregivers who enrolled closer to the patient's death. There were also significant individual differences in the effect of time within the study on QOL among caregivers ( 1j ϭ .009, SE ϭ .006, 2 [mixed 1/2, n ϭ 110] ϭ 5.3, p ϭ .04) but not patients.
Growth Models: Disease Severity
Growth models also examined the effect of disease severity (i.e., increased functional impairment on the ALSS) for both patients and caregivers (Model 3; Tables 2 and 3 ). The intercepts in these models represent average PIL or QOL at 1-point of functional impairment (i.e., ALSS ϭ 39), or disease start. For PIL, intercepts fell in the "definite" level of PIL (113.51 for patients, 119.41 for This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
caregivers). For QOL, intercepts fell between "content" and "happy" (3.10 for patients, 3.08 for caregivers). Coefficients represent change from 1-point increment increases in functional impairment on the ALSS. Increases in patient disease severity significantly predicted decreases in PIL in both patients and caregivers (patients, ␥ ϭ Ϫ0.62, t[463] ϭ Ϫ4.33, p Ͻ .001; caregivers, ␥ ϭ Ϫ0.59, t[352] ϭ Ϫ5.53, p Ͻ .001). There were significant individual differences in the effect of disease severity on PIL (i.e., a random effect) among patients (disease severity 1j ϭ .61, SE ϭ .29, 2 [mixed 1/2, n ϭ 130] ϭ 11.3, p ϭ .002) but not caregivers (see Supplementary Figure 1 for model estimates of the effect of disease severity on PIL). Increases in patient disease severity also significantly predicted decreases in both patients' and caregivers' QOL (patients, ␥ ϭ Ϫ0.03, t(467) ϭ Ϫ4.09, p Ͻ .001; caregivers, ␥ ϭ Ϫ0.02, t(353) ϭ Ϫ2.64, p ϭ .009). There were also significant individual differences in the effect of disease severity on QOL among caregivers (disease severity 1j ϭ .003, SE ϭ .001, 2 [mixed 1/2, n ϭ 110] ϭ 6.6, p ϭ .02) but not patients (see Supplementary Figure 2 of the online supplemental materials for model estimates of the effect of disease severity on QOL).
Dyadic Relationship Models
Unconditional means dyadic models examined between-dyad and within-dyad similarities. Positive between-dyad correlations indicated that dyad members were more similar to each other than to other dyads. Positive within-dyad correlations indicated that dyad members tended to fluctuate together in their PPH. For PIL, there were not statistically significant between-dyad similarities (between-dyad covariance ϭ 21.97, SE ϭ 25.02, p ϭ .38, r ϭ .10). However, PIL did significantly fluctuate together within the dyad; a small but statistically significant within-dyad correlation was observed (within-dyad covariance ϭ 14.97, SE ϭ 4.39, p Ͻ .001, r ϭ .19). Dyad members were not strongly similar to each other in their average PIL, but dyadic PIL fluctuated together.
For QOL, there were statistically significant between-dyad similarities; a moderate between-dyad correlation was observed (between-dyad covariance ϭ .18, SE ϭ 0.07, p ϭ .01, r ϭ .31). However, QOL did not fluctuate together within the dyad (withindyad covariance ϭ .02, SE ϭ 0.02, p ϭ .32, r ϭ .05). Dyad members were similar to each other in their average QOL, but dyadic QOL did not fluctuate together.
Finally, growth dyadic models examined disease severity as a predictor of dyadic covariance. For PIL, patient disease severity significantly predicted within-dyad covariance (patients, ␥ ϭ Ϫ0.71, t[593] ϭ Ϫ5.85, p Ͻ .001; caregivers, ␥ ϭ Ϫ0.56, t[460] ϭ Ϫ5.10, p Ͻ .001). Disease severity accounted for 44% of PIL within-dyad covariance (pseudo R 2 ϭ .44). For QOL, disease severity did not significantly predict between-dyad QOL mean covariance (pseudo R 2 ϭ .006). . This graph models the coefficients produced by Model 2a. Each line can be thought of as a modeling for a separate hypothetical person enrolled in the study at different proximities to their diagnosis date; zero on the x-axis represents diagnosis date. Each of these lines begins at the estimated PIL at study entry and ends at the estimated PIL at study completion. Therefore, slopes are estimated change over an 18-month period. There were statistically significant negative PIL slopes within 31 year quarters after diagnosis; after that point, slopes were not significantly different from zero. PIL ϭ purpose in life. See the online article for the color version of this figure.
Discussion
The aims of the current research were to evaluate the variance and covariance structures, trajectories, and dyadic coupling of PIL and self-assessed QOL in patients with ALS and their caregivers. An additional study aim was to examine change in PPH in relation to patient diagnosis and death. In particular, we expected that because PIL reflects eudaemonic PPH, it might be robust to objectively negative changes in life conditions, whereas QOL, weighted more heavily by hedonic PPH, would not. For patients with ALS and their caregivers, PIL was generally stable (i.e., more variance was from between-person differences in person-level means than from within-person deviations), whereas self-assessed QOL varied more over time (i.e., half of the variance was from within-person deviations from their person-level mean), consistent with our hypothesis. These results replicate previous findings that general QOL exhibited greater within-person fluctuation than an existential QOL subscale (i.e., reflecting eudaemonic PPH) in both patients with ALS and caregivers (Roach et al., 2009 ). These results suggest PIL and other eudaemonic aspects of PPH may be especially stable sources of well-being for patients with ALS and their caregivers.
However, critical periods exist for declines in PIL and QOL for patients and caregivers. Contrary to hypotheses, both patient and caregiver PIL and QOL significantly decreased in relation to disease severity and time, especially during critical periods. Over the 18-month study period, people who enrolled closest to diagnosis and closest to death both showed the steepest decrease in PIL, whereas people enrolled in the middle phase of the disease, furthest from diagnosis and death, had slower decline in PIL. There were some similar findings for QOL. It appears that phases of adjustment and adaptation occur for PPH in patients with ALS and their caregivers at different stages of the disease. It has been suggested that changes in expectations and response shift may contribute to stability in PPH (Cupp et al., 2011; Fegg et al., 2010; Neudert et al., 2004) . However, the current results also suggest that PIL and QOL are not stable at all stages of the disease. Patients and caregivers appear to be vulnerable to losses in PPH following diagnosis and approaching end of life. Patients with ALS and their caregivers may need increased support especially at diagnosis, when approaching death, and in periods of rapid physical decline. This phenomenon is likely not specific to patients with ALS and may apply to patients with other terminal illnesses (Murray et al., 2007) .
The extant literature on the effects of time and disease severity on QOL in ALS is somewhat discrepant from the reported findings. Several authors have concluded that general and self-assessed QOL remains preserved over the course of ALS despite physical decline (Neudert et al., 2004; Robbins et al., 2001; Simmons et al., 2000) , though not all research supports this conclusion (Rabkin et al., 2000; Roach et al., 2009) . However, the current study suggests Time is presented in year quarters (3-month increments). This graph models the coefficients produced by Model 2b. Each line can be thought of as a modeling for a separate hypothetical person enrolled in the study at different proximities to their date of death; zero on the x-axis represents date of death. Each of these lines begins at the estimated PIL at study entry and ends at the estimated PIL at study completion. Therefore, slopes are estimated change over an 18-month period. There were statistically significant negative PIL slopes within Ϫ45 year quarters before death; before that point, slopes were not significantly different from zero. PIL ϭ purpose in life. See the online article for the color version of this figure.
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that self-assessed QOL does not remain stable at all disease stages, with notable decreases following patient diagnosis, approaching patient death, and with increased disease severity. Several factors may underlie these discrepancies, including the assessment period, data collection proximity to death, QOL type, and statistical method. The current study assessed QOL and PIL over an 18-month period, with nearly half of the patient sample completing all visits (44.6%), whereas the majority of previous research evaluated change in QOL over shorter periods of time or had higher attrition rates. The current sample also included patients in different stages of the disease and included in-home assessments, allowing people with more advanced illness to participate. The majority of previous research has been conducted in conjunction with clinic visits, and patients with end-stage disease who were unable to travel may have been indirectly excluded. In addition, a variety of QOL types exist, including general QOL, health-related QOL, and self-assessed or single-item QOL. Health-related QOL produces different patterns over time and disease progression than other QOL indices (Neudert et al., 2004; Robbins et al., 2001; Simmons et al., 2000) . The discordance among different types of QOL measures in patients with ALS has been recognized as an important issue influenced by individual differences in patients' perceptions (Hardiman et al., 2004) . The current study utilized a self-assessed, single-item measure of QOL. Findings therefore reflect people's perceived QOL. Finally, the current study examined both mean-level and intraindividual variability in PPH. A recent longitudinal study in older veterans demonstrated that although mean-level analysis did not provide indication of change in PIL, intraindividual analysis indicated significant within-person changes over time (Hill, Turiano, Spiro, & Mroczek, 2015) . Therefore, without within-person assessments, trajectories may appear stable if averaged, masking individual differences. Results of the current study also suggest that patient and caregiver PPH are intertwined, although in different ways. Dyad members were similar to each other in their average self-assessed QOL, but QOL did not exhibit within-dyad coupling over time. Previous research supports this between-dyad QOL relationship; significant cross-sectional correlations between patients' and caregivers' general QOL (Rabkin et al., 2000) , health-related QOL (Jenkinson, Fitzpatrick, Swash, Peto, & ALS-HPS Steering Group, 2000) , and existential QOL (Pagnini et al., 2011) have been reported. The current study also provides novel evidence of longitudinal withindyad coupling for PIL in patients with ALS and their respective caregivers. We posit that QOL between-dyad relationships may reflect similar life conditions, whereas PIL within-dyad relationships may reflect a shared disease experience. In this case, PIL within-dyad coupling over time was largely explained by changes in patient disease severity. Furthermore, as the patient approaches death, it is plausible that patients and caregivers experience existential issues together. These results provide support for conceptualizing ALS as a family disease (Gauthier et al., 2007) , and extend this meaning to the reciprocal impact between patients and their family through the disease experience.
Clinical Implications
Although PIL was a stable psychological resource for ALS patients and caregivers, critical periods existed in which intervention may be needed most. Applying psychological interventions following patient diagnosis may mitigate future decline in PPH for both patients and their caregivers. The need for tailored psychological interventions for patients with ALS has been recognized (Bungener et al., 2005) . Early meaning or purpose-focused intervention (see LeMay & Wilson, 2008 , for a review) is in line with the theory of cognitive adaptation, in which people adjust to life-threatening events by searching for meaning, regaining mastery, and restoring self-esteem, which buffers future threats (Taylor, 1983 ).
Strengths and Limitations
Few previous studies have examined PPH, and particularly PIL, in patients with ALS and their caregivers in relation to patient diagnosis and death. Furthermore, our modeling strategy allowed for the assessment of between-person and within-person variance and covariance, changes in trajectories in relation to time and disease severity, and individual differences in trajectories. These findings suggest that PIL and QOL are dynamic processes impacted by critical time periods and disease severity. The relatively large sample size, large range in disease stage, and longitudinal design of the ALS Patient Profile Project (McDonald et al., 1994) permitted these dynamic processes to emerge.
The present study also has certain limitations. First, the study sample included some people with exceptionally slow rates of disease progression. The average survival time (i.e., date of diagnosis to patient death) was longer than what is generally reported in the literature (Ringel et al., 1993) . However, because the sample included people both near and far from critical periods (i.e., diagnosis and death), accounting for individual differences revealed important trajectory patterns. Additionally, QOL was evaluated with a single-item self-assessed measure that has not been previously validated. However, self-assessed QOL has been recognized as an important aspect of PPH in patients with ALS (Hardiman et al., 2004) and is included in validated QOL measures (McGill QOL Questionnaire; S. R. Cohen et al., 1995) . Finally, health care for patients with ALS has evolved since the study took place. Adaptive equipment has improved, which may impact patient autonomy and caregiver burden. Multidisciplinary care has been shown to improve QOL ( Van den Berg et al., 2005) . Data utilized in the current study was also collected prior to the Food and Drug Administration's approval of modern selective serotonin reuptake inhibitor antidepressants and Riluzole, the only pharmacological treatment for ALS. However, this treatment has minimal effect on disease course, and the current sample represents a natural history of PPH in ALS.
Conclusion
The present study provides important new insight into the variance and covariance structures, trajectories, and dyadic coupling of PIL and QOL in patients with ALS and their caregivers. In regard to total construct variance, PIL was more stable than QOL; PIL variance was primarily attributable to stable between-person differences. This stability suggests that PIL is a potential psychological resource for patients and caregivers. However, evaluation of the within-person variance in these constructs revealed periods of decline and stabilization for both PIL and QOL. In regard to within-person variance, time and disease severity were more delThis document is copyrighted by the American Psychological Association or one of its allied publishers.
eterious to PIL than to QOL. Factors other than disease severity, such as coping styles or disease education, may play a role in QOL variability. Finally, PIL and QOL in patients with ALS and their caregivers were interrelated. Average QOL between dyad members was significantly related, whereas PIL exhibited longitudinal within-dyad coupling. These findings build on the previous literature and highlight the dynamic and interwoven nature of PPH in patients with ALS and their caregivers, and provide avenues for future work investigating PIL as a resilience factor for people facing terminal illness and their caregivers.
